Vestcor Inc’s Royalty Pharma RPRX Stock Holding History

Vestcor Inc’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Hold	8,044	–	–	0.01%	812
2026 Q1	$386K	Hold	8,044	–	–	0.01%	826
2025 Q4	$311K	Hold	8,044	–	–	0.01%	869
2025 Q3	$284K	Hold	8,044	–	–	0.01%	897
2025 Q2	$290K	Sell	8,044 -37	-0.5%	-$1.23K	0.01%	883
2025 Q1	$252K	Hold	8,081	–	–	0.01%	905
2024 Q4	$206K	Hold	8,081	–	–	0.01%	979
2024 Q3	$229K	Hold	8,081	–	–	0.01%	935
2024 Q2	$213K	Hold	8,081	–	–	0.01%	927
2024 Q1	$245K	Sell	8,081 -59	-0.7%	-$1.74K	0.01%	889
2023 Q4	$229K	Sell	8,140 -80	-1%	-$2.2K	0.01%	949
2023 Q3	$223K	Hold	8,220	–	–	0.01%	946
2023 Q2	$253K	Sell	8,220 -73	-0.9%	-$2.47K	0.01%	777
2023 Q1	$299K	Hold	8,293	–	–	0.01%	768
2022 Q4	$328K	Buy	8,293 +90	+1%	+$3.76K	0.01%	771
2022 Q3	$330K	Buy	8,203 +145	+2%	+$6.19K	0.01%	788
2022 Q2	$339K	Buy	8,058 +2,624	+48%	+$108K	0.01%	784
2022 Q1	$212K	Buy	5,434 +1,218	+29%	+$47.8K	0.01%	917
2021 Q4	$168K	Buy	4,216 +1,602	+61%	+$62.2K	0.01%	912
2021 Q3	$94K	Sell	2,614 -317	-11%	-$12.3K	﹤0.01%	1010
2021 Q2	$120K	Buy	+2,931	New	+$125K	﹤0.01%	1008

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestcor Inc's RPRX Position: Q2 2026 in Review

Vestcor Inc held its Royalty Pharma (RPRX) position steady in Q2 2026 at 8,044 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #812.

Vestcor Inc first reported a position in RPRX in Q2 2021 and has held it in 21 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Vestcor Inc held 8,044 shares of Royalty Pharma worth $451K as of Q2 2026.
Vestcor Inc left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up 0.01% of Vestcor Inc's portfolio in Q2 2026, its #812 holding.
Vestcor Inc first reported a position in Royalty Pharma in Q2 2021 and has held it in 21 quarters since.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.